Giant Bladder Stones: A Rare Condition with Increasing Recognition

Giant bladder stones (GBS), defined as having a diameter greater than 4 cm or weighing over 100 g, are uncommon occurrences, particularly in developed nations. While historically more prevalent in tropical and developing countries, cases are being increasingly recognized elsewhere. This article explores the causes, symptoms, diagnostic approaches, and management strategies for GBS, with a focus on recent insights and clinical considerations.

What are Bladder Stones?

Bladder stones are solid masses formed from minerals that crystallize within the bladder. They are composed most commonly of magnesium ammonium phosphate, calcium oxalate, calcium phosphate, uric acid, and cystine.¹ These stones develop when urine remains stagnant in the bladder, allowing minerals to clump together. They represent approximately 5% of all urological stones.¹

Causes and Risk Factors

The primary driver of bladder stone formation is urinary stasis, often linked to underlying conditions such as benign prostatic hyperplasia (BPH) in men or neurogenic bladder dysfunction.² Several factors contribute to this stasis:

• Benign Prostatic Hyperplasia (BPH): An enlarged prostate can compress the urethra, obstructing urine flow and leading to incomplete bladder emptying.³
• Neurogenic Bladder: Conditions affecting nerve control of the bladder can impair its ability to contract and empty effectively.
• Urinary Tract Infections (UTIs): Chronic or recurrent UTIs can alter urine chemistry and promote stone formation, particularly with urease-producing bacteria.⁴
• Dietary Factors: Insufficient fluid intake, high oxalate consumption, low calcium intake, diets rich in certain plant foods (rice, wheat), and excessive sugar-sweetened beverage consumption have been correlated with bladder stone development.⁵
• Anatomical Defects: Structural abnormalities within the urinary tract can contribute to stasis.

Symptoms of Giant Bladder Stones

Symptoms of GBS can include:

• Recurrent urinary tract infections
• Hematuria (blood in the urine)
• Lower urinary tract symptoms (frequency, urgency, hesitancy)
• Pelvic pain
• Urinary retention

However, some individuals may experience minimal symptoms, particularly in the early stages.¹

Diagnosis

Diagnosis typically involves a combination of:

• Medical History and Physical Exam: Assessing symptoms and risk factors.
• Urinalysis and Urine Culture: To detect infection and analyze urine composition.
• Imaging Studies:
  • CT Scan: The preferred imaging modality for visualizing bladder stones, providing detailed information about size, shape, and location.¹
  • Ultrasound: Can be used as an initial screening tool, but may not be as accurate as CT scans.
  • Cystoscopy: Allows direct visualization of the bladder and urethra, but can be challenging with particularly large stones.

Management and Treatment

The management of GBS depends on the size, symptoms, and overall health of the patient. Treatment options include:

• Spontaneous Passage: Small stones may pass on their own, but this is unlikely with GBS.
• Transurethral Cystolithotripsy (TUCL): A minimally invasive procedure using a cystoscope to break up the stone into smaller fragments for removal.⁶ This is often the first-line treatment when feasible.
• Percutaneous Cystolithotomy: A surgical approach involving a small incision in the abdomen to access and remove the stone. This is particularly useful for very large stones or when urethral access is difficult.⁶
• Open Cystolithotomy: Traditional open surgery, offering the highest stone-free rate but with a greater risk of complications.⁶

In some cases, management of underlying conditions like BPH (e.g., transurethral resection of the prostate) may be necessary to prevent recurrence.⁷ Pharmacological dissolution is not typically effective for GBS due to their size and composition.⁸

Case Study and Stone Growth

A recent case report highlighted an 80-year-old male with a GBS who declined surgical intervention. Over three years, the stone grew at an estimated rate of 18 cm³ per year (41% per year).¹ While limited data exists on bladder stone growth rates, a recent study on renal stones showed an average growth rate of 25% over 43.41 months.⁹

Conclusion

Giant bladder stones are a rare but potentially significant urological condition. Early diagnosis and appropriate management are crucial to prevent complications. While open cystolithotomy remains the mainstay treatment, minimally invasive techniques like TUCL and percutaneous cystolithotomy are increasingly utilized. A thorough understanding of the underlying causes and risk factors is essential for effective prevention and treatment.

References

1. Prattley S, Voss J, Cheung S, et al. Ureteroscopy and stone treatment in the elderly (≥70 years): prospective outcomes over 5- years with a review of literature. Int Braz J Urol. 2018;44(4):750–757. Doi:10.1590/S1677-5538.IBJU.2017.0516
2. Mayo Clinic. Bladder stones – Symptoms & causes. https://www.mayoclinic.org/diseases-conditions/bladder-stones/symptoms-causes/syc-20354339 Accessed March 10, 2026.
3. HelpDementia. Why are elderly men more vulnerable to bladder stones? https://helpdementia.com/why-are-elderly-men-more-vulnerable-to-bladder-stones/ Accessed March 10, 2026.
4. Cleveland Clinic. Bladder Stones: Causes, Symptoms, Treatment & Removal. https://my.clevelandclinic.org/health/diseases/16312-bladder-stones Accessed March 10, 2026.
5. Gadelkareem AS, et al. Predictors of clinical and surgical characteristics in giant bladder stones in the “stone forming belt”. Urology. 2018;128:118-123.
6. Syarif H, et al. Giant bladder diverticulum associated with a large bladder stone: a case report. Int Urol Nephrol. 2011;43(4):1239-42.
7. de Castro Abreu M, et al. Stone growth in asymptomatic renal stones: a systematic review and meta-analysis. BMC Urol. 2022;22(1):288.